Moderate to Severe Allergic Asthma
4 clinical trials · Condition
◉ Watch Moderate to Severe Allergic Asthma
| Record | Firm | Date |
|---|---|---|
| A Clinical Study of Omalizumab in the Treatment of Allergic Asthma(ESSENCE) (NCT06348407) | The First Affiliated Hospital with Nanjing Medical University | 2023-12-01 |
| A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma (NCT04195958) | Genentech, Inc. | 2020-11-30 |
| CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma (NCT01673672) | Cytos Biotechnology AG | 2012-11-01 |
| Observational and Epidemiologic Study of the Disease Course and Unmet Needs in Children With Symptomatic Moderate to Severe Allergic Asthma (NCT01362621) | Novartis Pharmaceuticals | 2008-02-01 |
Track Moderate to Severe Allergic Asthma automatically
Every clearance here is in the API, with alerts when new ones post.